Position in SCLX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$140
+$21 QoQ
Shares Held
18
-37.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 72 holders
Holding Since
Sep 2022
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BNP PARIBAS ARBITRAGE, SA holds $4,776,233,341 across 18 Drug Manufacturers - General names. SCLX ranks #18 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
961,496 | $1,153,247,243 | |
| 2 | ABBV |
AbbVie Inc.
|
3,055,271 | $768,828,394 | |
| 3 | JNJ |
Johnson & Johnson
|
2,799,362 | $710,953,967 | |
| 4 | AMGN |
Amgen Inc
|
1,321,585 | $478,572,360 | |
| 5 | MRK |
Merck & Co., Inc.
|
3,130,937 | $402,325,404 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,536,332 | $320,440,184 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,492,542 | $316,480,270 | |
| 8 | PFE |
Pfizer Inc
|
10,704,871 | $257,773,293 |
All Filings in SCLX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $140 | 18 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $119 | 18 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $219 | 18 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $146,221 | 7,430 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $15,113 | 2,566 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,069 | 20,360 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $8,609 | 20,209 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||